Nuveen Preferred & Income Opportunities Fund is actively managed, investing primarily in preferred shares and other ...
Wave Life Sciences (WVE) stock rises on plans to file for FDA accelerated approval of WVE-N531 in 2026, targeting Duchenne muscular dystrophy. Read more here.
Raymond James Financial Inc. has acquired 300,100 shares of Nuveen Select Tax-Free Income Portfolio (NYSE:NXP).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback